It’s been a bit of a crazy week – it’s amazing what activities you’ll plan for yourself when you’re not working out. I seemed to think that I have extra hours on end due to not hitting the gym. Note to self: cool it. Therefore, I’m a bit light on posts this week, but here’s a few links to happenings that have perked up my ears lately:
Type 2 diabetes is STILL on the rise in California, and it’s still hitting minority populations disproportionately. With elections coming up and health care reform already in motion, diabetes is a more pertinant issue than ever. Beyone the lives at stake, diabetes is one of the most expensive issues in America these days – between lost work days and the cost of this disease, it could sink us faster than a double dib recession.
Newly diagnosed with Type 1 diabetes? Then you could be eligible to enroll in a clinical trial studying a medication that might help preserve beta cell function and halt Type 1 in it’s tracks. Click here for the details and sites where you can enroll.
In artificial pancreas news, it looks like MannKind Corporation will be providing their newly formulated, super rapid acting, oral insulin to the project. Check out their press release for details on their contributions to the project, and let’s all begin the countdown until a closed-loop system is available. I know I’m ready.
And if you’d really rather just waste some time today because you’re over it, look no further….
Comments
To add a comment to the original post, click here.
You must be signed in to post a comment.
Sign in nowThere are no comments for this post.